UsamaGergisMDMBA

PubMed

• 6 citations
  Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors
  Jack W. Hsu, Bronwen E. Shaw, Soyoung Kim, Brent R. Logan, Jennifer A. Sees
  Biology of Blood and Marrow Transplantation. 2020-06-01
• 201 citations
  Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Pa...
  Robert J. Soiffer, Haesook T. Kim, Joseph P. McGuirk, Mitchell E. Horwitz, Laura Johnston
  Journal of Clinical Oncology. 2017-10-17
• 77 citations
  Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transpla...
  Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori
  Transplantation and Cellular Therapy. 2021-08-01

Journal Articles

• The Addition Of Low Dose Total Body Irradiation To Fludarabine And Melphalan Conditioning In Haplo-Cord Transplantation For High Risk Hematological Malignancies  
  Choe HK, Gergis U, Mayer SA, Nagar H, Phillips AA, Shore TB, Smith MJ, van Besien K, Transplantation, 1/19/2016
• Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and survival free of progression and GVHD (GRFS)  
  Van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, Cushing MM, Korman ..., Haematologica, 1/11/2016
• Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors  
  Shanavas M, Popat U, Michaelis LC, Fauble V, McLornan D, Klisovic R, Mascarenhas J, Tamari R, Arcasoy MO, Davies J, Gergis U, Ukaegbu OC, Kamble RT, Storring JM, Majha..., Biol Blood Marrow Transplant, 1/1/2016
• Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated ...  
  Patel K, Parmar S, Shah S, Shore T, Gergis U, Mayer S, van Besien K, Biol Blood Marrow Transplant, 1/1/2016
• Cord blood chimerism and relapse after haplo-cord transplantation  
  van Besien K, Koshy N, Gergis U, Mayer S, Cushing M, Rennert H, Reich-Slotky R, Mark T, Pearse R, Rossi A, Phillips A, Vasovic L, Ferrante R, Hsu YM, Shore T, Leuk Lymphoma, 1/1/2016
• Spleen histology in myelofibrosis patients after hematopoietic stem cell transplant: a morphological and immunohistochemical study  
  Marco Pizzi, Usama Gergis, Felicia Chaviano, Attilio Orazi, Hematol Oncol Stem Cell Ther, 1/1/2016
• Cushing Engraftment for CD34 Selected Stem Cell Products is not compromised by Cryopreservation  
  Ronit Reich-Slotky, Lohith S. Bachegowda, Michael Ancharski, Usama Gergis, Koen van-Besien and Melissa M, Transfusion, 1/12/2015
• Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem ...  
  Satlin MJ, Vardhana S, Soave R, Shore TB, Mark TM, Jacobs SE, Walsh TJ, Gergis U, Biol Blood Marrow Transplant, 1/1/2015
• Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission  
  Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten..., Biol Blood Marrow Transplant, 1/1/2014
• A strategy to reduce donor-specific HLA Abs before allogeneic transplantation  
  Gergis U, Mayer S, Gordon B, Mark T, Pearse R, Shore T, Van Besien K, Bone Marrow Transplant, 1/1/2014
• Autologous stem cell transplant in human immunodeficiency virus-positive patients with lymphoid malignancies: focus on infectious complications Leuk Lymphoma  
  Morawa E, Martin P, Gergis U., van Besien K, Shore T, Leuk Lymphoma, 1/1/2013
• A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplantation in Multiple Myeloma  
  Tomer M. Mark MD, MSc, Whitney Reid, Ruben Niesvizky MD, Usama Gergis MD, Roger Pearse MD,PhD, Sebastian Mayer MD, June Greenberg RN, Morton Coleman MD, Koen Van Be..., Biol Blood Marrow Transplant, 1/1/2013
• A phase I study of CPX-351 in combination with Busulfan and Fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute l...  
  Usama Gergis, MD, Gail Roboz, MD , Tsiporah Shore, MD , Ellen Ritchie, MD, Sebastian Mayer, MD, Usama Wissa, MD, Marshall McKenna, Paul Christos, DrPH, Roger Pearse,..., Biol Blood Marrow Transplant, 1/1/2013
• Current status of allogeneic HST for chronic myelomonocytic leukemia  
  Cheng H, Kirtani VG, Gergis U, Bone Marrow Transplant, 1/1/2012
• Join now to see all

Books/Book Chapters

• Maternal Health 
  Chapter: Hematologic Malignancies in Pregnancy 
  Page 513 - 534Usama Gergis, Pinkal Desai, Adriana Rossi, Adrienne PhillipsEditors: Juise D. Pacheco, George R. Saade and Gary D.V. Hankins.McGraw Hill2015

Abstracts/Posters

• Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration
  Usama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion
  Usama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...
  Usama Gergis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant? 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Long term complications of bone marrow transplantation 
  King Faisal Research and Cancer Center, Riyadh, Saudi Arabia - 1/17/2017
• Cell Processing and HLA Typing 
  King Faisal Research and Cancer Center, Riyadh, Saudi Arabia - 1/15/2017
• Targeting the JAK Pathway in Patients Whose Polycythemia Vera 
  112 E 83rd St, New York, NY 10028 - 1/12/2016
• Defining uncontrolled Polycythemia Vera 
  Metropolitan Hospital, 1902 First Avenue, NY, NY 10029 - 1/8/2016
• The risk of invasive fungal infections in neutropenia and GVHD 
  Robert Wood Johnson University Hospital, New Brunswick, NJ - 1/2/2016
• PNH Regional Patient Meeting 
  Teaneck Marriott at Glenpointe, Teaneck, NJ, 2015; Intercontinental Hotel, New Orleans, LA, 2016 - 1/1/2016
• Understanding testing and monitoring for CML 
  Good Samaritan Hospital, Dayton, OH - 1/30/2015
• Antifungal prophylaxis in prolonged neutropenia 
  Brooklyn, NY, 2015; Beth Israel Deaconess Medical Center, Plymouth, MA, 2015 - 1/21/2015
• Pathophysiology of Polythysemis Vera 
  West Columbia, SC - 1/20/2015
• NORD Patient Meeting for Paroxysmal Nocturnal Hemoglobinuria 
  Brown Palace Hotel, Denver, CO - 1/16/2015
• Pathophysiology of aHUS 
  WDW Dolphin Hotel, Orlando, FL, 2015; Promise Hospital of Salt Lake, Salt Lake City, UT, 2015 - 1/14/2015
• Antifungal prophylaxis in prolonged neutropenia and GVHD 
  Indiana University, Indianapolis, IN - 1/13/2015
• Treatment of Ph+ CML in Chronic Phase 
  Jacksonville, FL - 1/3/2015
• Prognostic factors in MDS 
  1/24/2014
• Invasive Fungal Infection prophylaxis in patients with acute GVHD 
  Brooke Army Medical Center, San Antonio, TX - 1/24/2014
• Antifungal prophylaxi in acute GVHD 
  Tufts Medical Center, Boston, MA - 1/20/2014
• Pathophysiology of PNH 
  Dubai Hospital, UAE - 1/19/2014
• Cytogenetic Abnormalities in MDS 
  Brookdale University Hospital, Brooklyn, NY - 1/9/2014
• Refractory Leukemia, chemotherapy or transplant? 
  Hackensack Cancer Center, Hackensack, NJ - 1/11/2013
• Umbilical Cord Transplantation 
  Staten Island University Hospital, Staten Island, NY - 1/9/2013
• Refractory AML, can we do better? 
  Nassau County Hospital, Long Island, NY - 1/1/2013
• Umbilical cord blood transplantation 
  The Brooklyn Hospital Center, Brooklyn, NY - 1/1/2012
• Join now to see all